Tandem Diabetes Care, Inc. Capital Expenditures
Tandem Diabetes Care, Inc. (TNDM) reported Capital Expenditures of $10.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Tandem Diabetes Care, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $4.05M, a 34.74% decline year-over-year.
- Tandem Diabetes Care, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $6.27M, a 111.40% increase year-over-year.
- Tandem Diabetes Care, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $6.68M, a 117.82% increase year-over-year.
- Tandem Diabetes Care, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $4.09M, a 21.89% decline year-over-year.
- Tandem Diabetes Care, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $19.95M, a 3.73% increase from fiscal 2024.
- Tandem Diabetes Care, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $19.23M, a 28.25% decline from fiscal 2023.
- Tandem Diabetes Care, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $26.80M, a 21.39% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $34.10M, a 140.46% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.32M 10-Q · filed 2026-08-06 | $17.00M derived: sum of 3 quarters · filed 2026-08-06 | $21.09M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $6.27M 10-Q · filed 2026-05-07 | $12.95M derived: sum of 2 quarters · filed 2026-05-07 | $17.05M derived: sum of 3 quarters · filed 2026-05-07 | $23.25M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $6.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.78M derived: sum of 2 quarters · filed 2026-02-19 | $16.98M derived: sum of 3 quarters · filed 2026-08-06 | $19.95M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $4.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $10.30M derived: sum of 2 quarters · filed 2026-08-06 | $13.26M 10-Q · filed 2025-11-06 | $16.33M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $6.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.17M 10-Q · filed 2026-08-06 | $12.24M derived: sum of 3 quarters · filed 2026-08-06 | $17.48M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $2.96M 10-Q · filed 2026-05-07 | $6.03M derived: sum of 2 quarters · filed 2026-05-07 | $11.27M derived: sum of 3 quarters · filed 2026-05-07 | $17.74M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $8.31M derived: sum of 2 quarters · filed 2026-02-19 | $14.77M derived: sum of 3 quarters · filed 2026-02-19 | $19.23M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $5.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $11.71M derived: sum of 2 quarters · filed 2025-11-06 | $16.16M 10-Q · filed 2025-11-06 | $21.36M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | $6.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $10.92M 10-Q · filed 2025-08-06 | $16.12M derived: sum of 3 quarters · filed 2026-02-19 | $21.52M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | $4.46M 10-Q · filed 2025-04-30 | $9.66M derived: sum of 2 quarters · filed 2026-02-19 | $15.06M derived: sum of 3 quarters · filed 2026-02-19 | $22.43M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.60M derived: sum of 2 quarters · filed 2026-02-19 | $17.98M derived: sum of 3 quarters · filed 2026-02-19 | $26.80M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $5.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $12.78M derived: sum of 2 quarters · filed 2024-11-06 | $21.61M 10-Q · filed 2024-11-06 | $27.23M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | $7.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $16.20M 10-Q · filed 2024-08-01 | $21.83M derived: sum of 3 quarters · filed 2025-02-26 | $35.54M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | $8.83M 10-Q · filed 2024-05-02 | $14.46M derived: sum of 2 quarters · filed 2025-02-26 | $28.16M derived: sum of 3 quarters · filed 2025-02-26 | $40.28M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $5.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $19.34M derived: sum of 2 quarters · filed 2025-02-26 | $31.45M derived: sum of 3 quarters · filed 2025-02-26 | $34.10M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $13.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $25.83M derived: sum of 2 quarters · filed 2023-11-01 | $28.47M 10-Q · filed 2023-11-01 | $34.22M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $12.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $14.76M 10-Q · filed 2023-08-03 | $20.51M derived: sum of 3 quarters · filed 2024-02-21 | $23.60M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $2.64M 10-Q · filed 2023-05-03 | $8.39M derived: sum of 2 quarters · filed 2024-02-21 | $11.48M derived: sum of 3 quarters · filed 2024-02-21 | $13.30M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $5.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $8.84M derived: sum of 2 quarters · filed 2024-02-21 | $10.66M derived: sum of 3 quarters · filed 2024-02-21 | $14.18M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $4.91M derived: sum of 2 quarters · filed 2022-11-02 | $8.43M 10-Q · filed 2022-11-02 | $12.53M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $5.34M 10-Q · filed 2022-08-03 | $9.44M derived: sum of 3 quarters · filed 2023-02-22 | $16.20M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | $3.52M 10-Q · filed 2022-05-04 | $7.62M derived: sum of 2 quarters · filed 2023-02-22 | $14.38M derived: sum of 3 quarters · filed 2023-02-22 | $24.17M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $10.86M derived: sum of 2 quarters · filed 2023-02-22 | $20.64M derived: sum of 3 quarters · filed 2023-02-22 | $27.41M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $6.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $16.55M derived: sum of 2 quarters · filed 2021-11-03 | $23.31M 10-Q · filed 2021-11-03 | $30.06M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | $9.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $16.55M 10-Q · filed 2021-08-04 | $23.30M derived: sum of 3 quarters · filed 2022-02-22 | $27.92M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | $6.77M 10-Q · filed 2021-05-05 | $13.52M derived: sum of 2 quarters · filed 2022-02-22 | $18.14M derived: sum of 3 quarters · filed 2022-02-22 | $24.90M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | $6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $11.37M derived: sum of 2 quarters · filed 2022-02-22 | $18.13M derived: sum of 3 quarters · filed 2022-02-22 | $19.54M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $4.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $11.38M derived: sum of 2 quarters · filed 2020-11-05 | $12.79M 10-Q · filed 2020-11-05 | $13.68M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $6.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $8.17M 10-Q · filed 2020-07-30 | $9.06M derived: sum of 3 quarters · filed 2021-02-24 | $10.07M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | $1.41M 10-Q · filed 2020-04-30 | $2.30M derived: sum of 2 quarters · filed 2021-02-24 | $3.31M derived: sum of 3 quarters · filed 2021-02-24 | $3.88M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $888.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.90M derived: sum of 2 quarters · filed 2021-02-24 | $2.47M derived: sum of 3 quarters · filed 2021-02-24 | $2.99M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $1.58M derived: sum of 2 quarters · filed 2019-11-04 | $2.10M 10-Q · filed 2019-11-04 | $3.52M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $573.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $1.09M 10-Q · filed 2019-08-01 | $2.51M derived: sum of 3 quarters · filed 2020-02-24 | $2.75M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | $514.00K 10-Q · filed 2019-04-30 | $1.93M derived: sum of 2 quarters · filed 2020-02-24 | $2.18M derived: sum of 3 quarters · filed 2020-02-24 | $3.59M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $1.66M derived: sum of 2 quarters · filed 2020-02-24 | $3.08M derived: sum of 3 quarters · filed 2020-02-24 | $5.72M 10-K · filed 2020-02-24 | |||
| 2017-09-30 | $244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.66M derived: sum of 2 quarters · filed 2018-11-01 | $4.30M 10-Q · filed 2018-11-01 | $7.04M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | $4.05M 10-Q · filed 2018-07-30 | $6.80M derived: sum of 3 quarters · filed 2019-02-26 | $8.94M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $2.64M 10-Q · filed 2018-04-26 | $5.39M derived: sum of 2 quarters · filed 2019-02-26 | $7.53M derived: sum of 3 quarters · filed 2019-02-26 | $9.63M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $4.88M derived: sum of 2 quarters · filed 2019-02-26 | $6.99M derived: sum of 3 quarters · filed 2019-02-26 | $8.93M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $4.24M derived: sum of 2 quarters · filed 2017-10-26 | $6.19M 10-Q · filed 2017-10-26 | $7.86M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $4.05M 10-Q · filed 2017-07-27 | $5.72M derived: sum of 3 quarters · filed 2018-03-01 | $7.46M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $1.95M 10-Q · filed 2017-04-27 | $3.62M derived: sum of 2 quarters · filed 2018-03-01 | $5.36M derived: sum of 3 quarters · filed 2018-03-01 | $7.11M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $3.41M derived: sum of 2 quarters · filed 2018-03-01 | $5.16M derived: sum of 3 quarters · filed 2018-03-01 | $5.76M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $3.49M derived: sum of 2 quarters · filed 2016-11-01 | $4.09M 10-Q · filed 2016-11-01 | $4.84M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $2.35M 10-Q · filed 2016-07-28 | $3.10M derived: sum of 3 quarters · filed 2017-03-08 | $4.07M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-03-31 | $600.00K 10-Q · filed 2016-04-28 | $1.35M derived: sum of 2 quarters · filed 2017-03-08 | $2.32M derived: sum of 3 quarters · filed 2017-03-08 | $3.39M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2014-12-31 | $746.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $1.72M derived: sum of 2 quarters · filed 2017-03-08 | $2.79M derived: sum of 3 quarters · filed 2017-03-08 | $4.41M 10-K · filed 2017-03-08 | |||
| 2014-09-30 | $970.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $2.04M derived: sum of 2 quarters · filed 2015-10-29 | $3.66M 10-Q · filed 2015-10-29 | $5.26M 10-Q · filed 2014-11-06 | $5.14M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $2.69M 10-Q · filed 2015-07-30 | $4.29M 10-Q · filed 2014-07-31 | $4.17M derived: sum of 3 quarters · filed 2016-02-24 | $5.28M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $1.62M 10-Q · filed 2015-04-30 | $1.62M 10-Q · filed 2014-05-06 | $3.10M derived: sum of 2 quarters · filed 2016-02-24 | $4.21M derived: sum of 3 quarters · filed 2016-02-24 | $4.73M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $2.59M derived: sum of 2 quarters · filed 2016-02-24 | $3.11M derived: sum of 3 quarters · filed 2016-02-24 | $4.01M 10-K · filed 2016-02-24 | |||
| 2013-09-30 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.63M derived: sum of 2 quarters · filed 2014-11-06 | $2.53M 10-Q · filed 2014-11-06 | ||||
| 2013-06-30 | $514.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $1.42M 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | $901.11K 10-Q · filed 2014-05-06 | ||||||
| 2012-12-31 | $4.53M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |